Stock · EL.PA · Healthcare

EssilorLuxottica S. A.

France · Large Cap · Revenue 12 mo. €29.3B

Price as of 11/06/2026

StockScorer score
3.6
of 10 4 of 11 points Low Match To the score
Price
€193.80
1 Y −47.6%
Market cap
€87.6B
Phase
Growth
revenue growing, core business profitable
Revenue +5.2% a year (3 years)EBIT margin 12.1%Payout 41.3% of operating cash flow

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, sunglasses, and instruments and equipment in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific.

moreless

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, sunglasses, and instruments and equipment in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific. It offers lens, eyewear, contact lenses, reading glasses under Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir Optical, eyexpert, iWear, Humanware, Optifog, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native Eyewear and Bolon, and Foster Grant brands. The company also provides vision assessment, eye pathology diagnosis and treatment, finishing equipment, fitting parameter measurement, small tools, and consumables. In addition, it offers SPECTRALIS, a multimodal imaging platform for diagnosis and treatment; RetinAI; Espansione Group; Cellview Imaging; ANTERION, a multidisciplinary all-in-one anterior segment imaging solution for measurements; apparel, footwear and accessories; and high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. Further, the company designs, develops, markets, and maintains diagnostics, refraction, lens edging and mounting instruments for opticians and prescription laboratories, and measurement; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It sells its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and consumers through the network of brick and mortar retail networks and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.

Original text from the data provider

Summary

EssilorLuxottica S. A. is around the middle of the Healthcare sector overall

43.3 of 100

Mean of the six area values. Each area value is the mean of the stock's ranks among the companies in its sector. 50 is the middle of the sector, not a share of companies beaten.

Analysis

What the price requires

The price requires 10.3% FCF growth a year: more than over the last 5 years, less than over the last 10 years.

If free cash flow stays at €3.8B (2025), it supports €41.8B. The remaining €45.8B of the market value assume it grows 10.3% a year for 10 years and not at all afterwards.

Required FCF growth per year

10.3%

no growth afterwards

Market value breakdown€87.6B market value, price as of 11/06/2026

€41.8B without growth
€45.8B priced-in growth
  • 5 yrs achieved 5.0%
  • 10 yrs achieved 18.4%
  • priced in 10.3%

Valuation against its own history

Price to operating cash flow 17.0×, below its usual range.

Middle half of 13 quarters: 17.6× to 22.3×, median 19.5×.

Measures only against its own past, not against what the company is worth. Price as of 11/06/2026.

2 signs support the expectation, 1 speaks against it.

What supports it

with respect to the priced-in expectation

  • High, stable gross margin median 62.3%, range 5.0 pp (10 years)
  • Steady FCF margin at least 10.2%, range 7.5 pp (10 years)

What speaks against it

with respect to the priced-in expectation

  • Share count rising despite money spent on own shares shares +1.0% year on year

Since the last quarter

Q1 → Q3 2026

A mixed quarter: 1 figure better, 1 worse.

  • Net debt€10.9B → €13.4B+23.3%worse
  • Shares outstanding469M → 464M−1.0%better

6 more unchanged: Revenue, 12 mo., FCF, 12 mo., Gross margin, EBIT margin, FCF margin, Return on equity

Derivation

How the sector comparison is derived

Each area value is the average of its metrics' ranks within the sector (0 to 100, 50 is the middle). For metrics where lower is better, the rank is mirrored. The overall value is the average of the area values.

Price as of 11/06/2026.

Profitability41.0around the middleEarns about as much as the sector.
MetricStockSector medianPosition in sector
Return on equity5.95%11.52%Rank 20
Return on capital (Greenblatt)38.15%32.55%Rank 60
EBIT margin12.11%18.31%Rank 31
FCF margin13.22%14.12%Rank 46
Gross margin60.56%60.99%Rank 49
Growth62.7above the middleGrows faster than the sector: Earnings growth, 5 years per year 91.47%, sector 7.00%.
MetricStockSector medianPosition in sector
Revenue growth, 1 year7.48%8.04%Rank 49
Earnings growth, 3 years per year1.05%5.44%Rank 37
Earnings growth, 5 years per year91.47%7.00%Rank 99
Sustainable growth (ROE × retained earnings)5.35%3.66%Rank 67
Valuation46.0around the middleValued about like the sector.
MetricStockSector medianPosition in sector
Earnings yield2.57%2.90%Rank 39
FCF yield4.30%3.63%Rank 58
EV/saleslower is better3.464.03Rank 55
EV/EBITlower is better28.5321.73Rank 32
Momentum24.5below the middleShare price doing worse than the sector: Share price, 1 year −47.63%, sector 8.66%.
MetricStockSector medianPosition in sector
Share price, 1 year−47.63%8.66%Rank 4
Share price, 6 months13.55%24.27%Rank 33
Share price, 3 months17.61%15.42%Rank 57
Distance from 52-week high−39.57%−7.35%Rank 5
Quality33.7below the middleQuality below the sector: Change in share count 1.01%, sector 0.00%.
MetricStockSector medianPosition in sector
Accruals (Sloan)lower is better−0.53%0.30%Rank 58
Change in share countlower is better1.01%0.00%Rank 14
Dividend streak in years410Rank 46
Price reaction to results, market-adjusted−4.25%0.05%Rank 17
Balance sheet & risk51.9around the middleRisk about like the sector.
MetricStockSector medianPosition in sector
Equity ratio60.86%48.40%Rank 69
Net debt/EBITDAlower is better1.661.11Rank 39
Debt to equitylower is better0.370.48Rank 57
Volatility, 1 yearlower is better33.84%31.42%Rank 43

Ten years in figures

Revenue from €7.1B (2016) to €28.5B (2025), 16.7% a year.

Fiscal years, amounts in EUR
YearRevenue, €BEBIT marginFCFSharesNet debt
20167.117.9%€900.0M219M€2.1B
20179.218.2%€939.0M221M€740.0M
201810.814.0%€1.6B266M€3.9B
201917.412.0%€2.4B441M€4.6B
202014.45.0%€2.3B439M€7.2B
202119.813.0%€3.5B445M€11.4B
202224.513.3%€3.2B446M€10.4B
202325.412.5%€3.3B451M€9.1B
202426.513.0%€3.4B460M€11.0B
202528.512.1%€3.8B465M€10.9B
3.6 / 10Low MatchStockScorer score4 of 11 points

2 of 7 StockScorer Score rules met · How the score is built

EssilorLuxottica S. A. mainly meets criteria in the Valuation category. Result from 18 strategies checked.

This stock · Profitability: 33%This stock · Growth: 0%This stock · Valuation: 100%This stock · Momentum: 0%Median of all stocks · Profitability: 33%Median of all stocks · Growth: 0%Median of all stocks · Valuation: 0%Median of all stocks · Momentum: 0%50%100%ProfitabilityGrowthValuationMomentumThis stockMedian of all stocks

How EssilorLuxottica S. A.'s score is built

EssilorLuxottica S. A. is rated here with the StockScorer Score strategy, the flagship rule set. It compares return and cash-flow metrics with the median of the company's own sector and checks growth and price trend.

2 of 7 rules met

4 of 11 points

  1. Free cash flow yield above the sector medianmet2 of 2 points
  2. Return on capital (Greenblatt ROC) above the sector medianmet2 of 2 points
  3. Return on equity above the sector mediannot met0 of 1 point
  4. Free cash flow margin above the sector mediannot met0 of 2 points
  5. Revenue growth above 15%not met0 of 2 points
  6. 3-year earnings growth above 12% p.a.not met0 of 1 point
  7. 12-month share price more than 20 percentage points ahead of the marketnot met0 of 1 point
  8. Exclusion: financial and real estate stocksdoes not apply

Detail data

How does EssilorLuxottica S. A. stock perform across 18 strategies?

Excerpt from 18 strategies checked. The full evaluation is visible after a free sign-up.

12 more strategies locked

With a free account, you can see the match across all strategies checked in one complete overview.

  • Undervalued Stocks: Multi-Factor Check
  • Balanced GARP
  • Magic Formula: Value + Quality
  • Trending Value: Value + Momentum
  • Defensive: Low Volatility
  • Moat Quality
  • Acquirer's Multiple: EV/EBIT Deep Value
  • Dividend Aristocrats & Continuity
  • Dividend Quality: 4 Factors
  • High-Growth / Rule of 40
  • Levermann Strategy (13 Criteria)
  • Growth Momentum (CAN SLIM principle)

EssilorLuxottica S. A. key metrics: P/E, P/B and equity ratio

Selected fundamental metrics for EssilorLuxottica S. A.

MetricStockSector
P/E ratio38.930.0
P/B ratio2.34.8
Return on equity (ROE)6.0%11.5%
Equity ratio60.9%48.4%
Debt-to-equity (D/E)0.370.48
Dividend yield2.1%1.3%

Similar stocks in Healthcare

How comparable stocks in the same sector score in the StockScorer model.

SymbolCompanyRating
EL.PAEssilorLuxottica S. A.this page
BDXBecton Dickinson and CompanyLow2.7
7741.THoya Corlocked
MDLNMedline Inc. Class A Common Stocklocked
ALC.SWAlcon AGlocked
RMDResMed Inclocked

Frequently asked questions about EssilorLuxottica S. A. stock

How does EssilorLuxottica S. A. stock (EL.PA) score in the StockScorer model?
EssilorLuxottica S. A. stock reaches a StockScorer score of 3.6 out of 10, which is a low match with the rule-based strategies. 2 out of 7 flagship profile rules are met.
What is EssilorLuxottica S. A.'s P/E ratio?
EssilorLuxottica S. A.'s P/E ratio is 38.9. The Healthcare sector median is 30.0.
What sector is EssilorLuxottica S. A. in?
EssilorLuxottica S. A. is assigned to the Healthcare sector. Its rank within the sector is 43.3 out of 100: 100 means the stock leads its peer group of large and mid-cap sector stocks in every measured area.

Unlock the full analysis for free

Signed up in 30 seconds, free.

  • More metrics: FCF margin, cash flow yield and more
  • Full peer comparison within the same sector
  • See the match across all strategies in detail
  • Apply your own scoring profile to any stock
  • Add the stock to your watchlist and track score changes
  • Daily updated ratings, rule-based and transparent

Learn more about the metrics in the metrics glossary or all rated stocks in the stock overview.

How StockScorer rates every stock is explained on the methodology page.